SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-032265
Filing Date
2023-07-07
Accepted
2023-07-07 16:30:49
Documents
14
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sqz-20230630.htm   iXBRL 8-K 65164
2 EX-10.1 sqz-ex10_1.htm EX-10.1 15672
3 GRAPHIC img143354312_0.jpg GRAPHIC 4139
  Complete submission text file 0000950170-23-032265.txt   213910

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sqz-20230630_lab.xml EX-101.LAB 14572
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sqz-20230630_pre.xml EX-101.PRE 11932
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sqz-20230630.xsd EX-101.SCH 2465
8 EXTRACTED XBRL INSTANCE DOCUMENT sqz-20230630_htm.xml XML 4938
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 231077133
SIC: 2836 Biological Products, (No Diagnostic Substances)